Resources

Filter by

September 3, 2026
Blog

5 Questions Biopharma IT Leaders Should Ask Before Approving AI in Their Data Environment

AI

August 27, 2026
Blog

Gross-to-Net Strategic Enablement: Giving Finance a Seat at the Table

Gross-to-Net

August 3, 2026
Blog

From AI Hype to AI You Can Trust

AI

July 13, 2026
Blog

How Leading Biopharma Organizations Are Preparing for the Next Era of Commercialization

Market Access

June 8, 2026
Blog

Channel Evolution: When Does Direct-to-Patient Become Relevant for Specialty Pharmaceuticals?

Contracts & Pricing

June 4, 2026
Blog

Rethinking Cash’s Role in Your Pharma Market Access & Pricing Strategy

Market Access

May 21, 2026
Blog

From Reactive to Proactive: How Drug Manufacturers Can Stay Ahead of Federal & State Reporting Requirements

Market Access

April 14, 2026
Blog

340B Program Update: Rebate Model, Contract Pharmacies, Duplicate Discounts, & What Manufacturers Need to Know

340B

March 19, 2026
Blog

Considerations for Branded Prescription Drug Fees

Contracts & Pricing

March 11, 2026
Blog

The Launch Lens: Trends in Payer Management Across Archetypes for New Market Entrants

Contracts & Pricing

March 3, 2026
Blog

The Evolving Role of Trade & Channel Data in Net Revenue Management

Managed Services

February 5, 2026
Blog

Technical Evolution of Net Revenue Management: Precision Data Architecture, Validation Logic, & Platform-Driven Control

Gross-to-Net